Speakers
Elisa Kawamoto
Elisa Kawamoto is a professor at the Institute of Biomedical Sciences of the University of São Paulo (ICB-USP), with extensive experience in Neuropharmacology and Neuroscience. She holds a degree in Pharmacy-Biochemistry from USP, and a master's and doctorate in Pharmacology from the same institution. She completed an internship at the National Institute on Aging (NIA), where she studied the Wnt protein and neuroprotection, in addition to postdoctoral studies at ICB-USP and NIA. As a Young Investigator funded by FAPESP, she is dedicated to research on hormesis, synaptic plasticity, aging and neurodegeneration, combining biochemical, behavioral and electrophysiological approaches to investigate fundamental mechanisms of brain function.
Mark Mattson
Mark Mattson is a renowned neuroscientist and former chief of the Laboratory of Neuroscience at the National Institute on Aging (NIA). With a background in biology and a Ph.D. from the University of Iowa, his work focuses on neuroplasticity, neurodegenerative diseases, and the effects of calorie restriction and intermittent fasting on brain health. Recognized as a leading authority on these topics, he has written the books The Intermittent Fasting Revolution and Sculptor and Destroyer, and hosts the Brain Ponderings podcast. His work on the neurotransmitter glutamate has made fundamental contributions to our understanding of Alzheimer’s and its metabolic impact on the brain.
Marcelo Alves da Silva Mori
Marcelo Alves Mori is an associate professor at the Institute of Biology of the University of Campinas (UNICAMP), where he researches the Biology of Aging and Metabolism. He holds a degree in Biological Sciences from UNIFESP, where he obtained his PhD in Molecular Biology with an internship at the Max-Delbrück Center (Germany) and completed a postdoctoral fellowship at the Joslin Diabetes Center of Harvard Medical School. His academic career includes leadership positions at UNICAMP, such as department head and research coordinator. His research focuses on the molecular mechanisms of metabolic syndrome and aging, and he is a former affiliated member of the Brazilian Academy of Sciences.
Garrie Arumugam
Garrie Arumugam é professor e pesquisador dedicado ao estudo da neurodegeneração, acidente vascular cerebral e demência vascular. Formado em Ciências Médicas pela Universidade de Sydney e doutor em Farmacologia pela Universidade de Queensland, realizou pós-doutorado nos EUA, incluindo o National Institute of Health sob a orientação de Mark Mattson. Estabeleceu seu laboratório independente na Texas Tech University antes de ingressar na Universidade Nacional de Singapura e, posteriormente, na La Trobe University. Com mais de 200 publicações em periódicos de alto impacto, seus estudos exploram a morte celular neuronal e os efeitos do jejum intermitente no envelhecimento cerebral
Caio Henry Yokoyama Mazucanti
Caio Henrique Mazucati is a researcher at the National Institutes of Health (NIH) and a specialist in Neurophysiology. He holds a degree in Pharmacy-Biochemistry from USP and a master's and doctorate in Pharmacology from the same institution. His work addresses topics such as Alzheimer's, neuroprotection and neurodegeneration, with a focus on the action of streptozotocin as an experimental model for studies of dementia. His academic and scientific career contributes to the understanding of the mechanisms involved in neurodegenerative diseases and possible therapeutic approaches.
Juan Carlos Leza
Juan Carlos Lenza is a professor in the Department of Pharmacology and Toxicology at the Faculty of Medicine of the Complutense University of Madrid, Spain. His research focuses on the pharmacological and toxicological mechanisms that impact human health, contributing to the advancement of knowledge in the field and the development of innovative therapeutic strategies.
Susana Gonzalo
Biologist and biochemist, graduated from the Universidad Complutense de Madrid, with a PhD from the Washington University School of Medicine. Her postdoctoral research included groundbreaking research on the retinoblastoma protein family and telomere epigenetics, opening new perspectives on the biology of aging. Professor in the Department of Biochemistry and Molecular Biology at Saint Louis University, she leads studies on genomic stability, the role of nuclear lamins and their relationship with cancer and diseases associated with premature aging, such as Hutchinson-Gilford Progeria Syndrome (HGPS). Her work has revealed similarities between the molecular mechanisms of accelerated aging and aggressive cancers, in addition to demonstrating the therapeutic potential of vitamin D. An international leader in aging research, she has participated in leading conferences in the field, contributing to the understanding of the biological processes that govern longevity and genome stability.
Lydia Mitiko Yshii
Immunologist, focusing on the role of T cells in neuroinflammatory and neurodegenerative diseases. His research explores the interaction between the immune system and the nervous system, contributing to the understanding of diseases such as multiple sclerosis and other inflammatory conditions of the brain.
Daniel C. Berwick
Senior Lecturer in Biomedical Sciences at St. George's, University of London, working on education and research projects on aging and neurodegeneration. He has a background in medical biochemistry and biotechnology, with a PhD in neuronal signaling. His research includes research on the Akt/PKB kinase, learning and neuronal gene expression, and the involvement of the LRRK2 protein in the Wnt signaling pathway.
Bonnie Firestein
Professor at Rutgers University and member of the American Institute for Medical and Biological Engineering and the American Association for the Advancement of Science. Her interdisciplinary team investigates cellular and molecular mechanisms in neuroscience, with applications in biomedical engineering and cell biology. She works on training students and researchers, consolidating her position as a reference in applied neuroscience.
Christopher Scavone
Farmacologista e neurocientista, professor titular do Departamento de Farmacologia do ICB-USP e membro da Academia de Ciências do Estado de São Paulo. Com pós-doutorado na Harvard Medical School, sua pesquisa foca no envelhecimento e nos processos inflamatórios envolvidos em doenças neuropsiquiátricas e neurodegenerativas. Seus estudos abordam plasticidade sináptica e neuroproteção, explorando a influência de fatores ambientais como dieta intermitente e exercício físico.
Henning Ulrich
Full professor at the Chemistry Institute of USP, with a degree in biology and a PhD in neuroscience from the University of Hamburg. Specialist in the pharmacology of purinergic receptors and neurodegeneration, he researches aptamer selection techniques and cellular mechanisms involved in psychiatric and neurodegenerative diseases. Internationally recognized, he was a Fulbright researcher at Rutgers Medical School and is on the list of the most influential scientists in the world.
Nadja Cristhina de Souza Pinto
Full professor at the Chemistry Institute of USP, with a PhD in molecular biology from UNIFESP. Her research focuses on DNA metabolism and repair, with an emphasis on mitochondrial DNA. Former president of the Brazilian Society of Mutagenesis and Environmental Genomics, she was a member of CTNBio in the area of Human Health.
Anna Takakura
She is a dentist, holds a master's and doctorate in pharmacology from UNIFESP, and completed her doctoral internship at the University of Virginia. She is an associate professor at ICB-USP and General Secretary of FeSBE. She researches the regulation of respiration by the central nervous system and its alterations in neurodegenerative diseases, such as Parkinson's, using electrophysiological and neuroanatomical approaches.
Luiz Roberto Giorgetti de Britto
Full professor at USP, with postdoctoral studies at the University of California, San Diego. A neuroscience specialist, his research focuses on cellular communication in the nervous system and neurodegenerative diseases. He has held several academic leadership positions and is a member of the Brazilian Academy of Sciences, contributing significantly to the advancement of knowledge in physiology and neurobiology.